StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report report published on Thursday. The brokerage issued a sell rating on the stock.
Bio-Path Price Performance
BPTH opened at $0.18 on Thursday. Bio-Path has a fifty-two week low of $0.12 and a fifty-two week high of $7.67. The company’s 50-day moving average is $0.36 and its 200 day moving average is $0.73.
About Bio-Path
Featured Articles
- Five stocks we like better than Bio-Path
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What Are the U.K. Market Holidays? How to Invest and Trade
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Why is the Ex-Dividend Date Significant to Investors?
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Bio-Path Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Path and related companies with MarketBeat.com's FREE daily email newsletter.
